ESC 2023 Update: Patients urged to be vigilant about cardiac infections Dr. Kamal Kant Kohli28 Aug 2023 9:30 AM IST Patients with specific cardiac conditions such as valvular heart disease and congenital abnormalities, or those requiring a pacemaker, should...
Structural valve deterioration tied to worse outcomes; favorable for TAVI versus surgery patients: JAMA Medha Baranwal21 Dec 2022 10:15 AM ISTFive-year structural valve deterioration is associated with worse clinical outcomes, favoured patients with a self-expanding TAVR placed instead of...
Apixaban better than rivaroxaban for AF patients with valvular heart disease: study dr. Abhimanyu Uppal28 Oct 2022 12:15 PM ISTAlthough apixaban and rivaroxaban are commonly used in patients with atrial fibrillation (AF) and valvular heart disease (VHD), there is limited...
Stroke, systemic embolism risk halved in AF patients with VHD who took apixaban versus Rivaroxaban Dr. Kamal Kant Kohli20 Oct 2022 11:45 AM ISTAccording to researchers at the Perelman School of Medicine at the University of Pennsylvania patients of Atrial fibrillation with VHD receiving...
2022 heart failure guidelines issued by ACC, AHA, HFSA Dr. Kamal Kant Kohli4 April 2022 10:30 AM ISTThe American College of Cardiology, the American Heart Association, and the Heart Failure Society of America have issued 2022 guidelines on Management...
2021 ESC/EACTS Guidelines for management of valvular heart disease- Aortic stenosis Dr. Nandita Mohan20 Dec 2021 11:30 AM ISTMedical Dialogues interacts with Dr O P Yadava, a Cardiothoracic surgeon who has given his expert insights on the European Society of Cardiology (ESC)...
Concomitant tricuspid valve repair improves outcomes of post-mitral valve replacement: NEJM dr. Abhimanyu Uppal2 Dec 2021 11:15 AM ISTTricuspid regurgitation is common in patients with severe degenerative mitral regurgitation. However, the evidence base is insufficient to inform a...
2021 ESC guideline on Valvular heart diseases: Single antiplatelet recommended post TAVI and more. dr. Abhimanyu Uppal30 Aug 2021 12:30 PM ISTThe ESC Congress, being held in a virtual format this year released update of the European Society of Cardiology (ESC) Guidelines for management of...
Transcatheter therapies, future of tricuspid regurgitation management: Glances from EuroPCR 2021 dr. Abhimanyu Uppal25 May 2021 10:30 AM ISTTranscatheter therapies for tricuspid valve disease are ready to take the front seat in management of tricuspid valve disease, as evidenced by three...
DOACs Better than Warfarin in Patients with Valvular Atrial Fibrillation, finds study MD Bureau31 March 2021 9:26 AM ISTAtrial fibrillation (AF) affects 5.2 million Americans, results in 158 000 deaths annually, and increases the risk for stroke. Although warfarin has...
AVR in young: Is Ross procedure the perfect answer? Study reports excellent outcomes dr. Abhimanyu Uppal12 March 2021 9:34 PM ISTJAMA Cardiology: There is no perfect prosthetic valve substitute for young and middle-aged patients requiring aortic valve replacement (AVR). The...
Valvosoft: fresh hope to AS patients unfit for valve replacement. dr. Abhimanyu Uppal2 Feb 2021 11:53 AM ISTCalcific aortic stenosis (CAS) is currently the most common heart valve disease and to date only surgical or transcatheter aortic valve replacement...
